Suppr超能文献

前列腺癌干细胞。

Prostate cancer stem cells.

作者信息

Romańska-Knight Hanna, Abel Paul

机构信息

Department of Molecular Pathology and Neuropathology, Medical University of Łódź, Poland.

Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, London, Great Britain.

出版信息

Cent European J Urol. 2011;64(4):196-200. doi: 10.5173/ceju.2011.04.art1. Epub 2011 Dec 9.

Abstract

The Cancer Stem Cells (CSCs) hypothesis postulates that a minute subpopulation of cells is accountable for cancer initiation and progression. Unlike the stochastic and clonal evolution models, the CSC theory proposes that tumours are hierarchical and only the rare subset of cells at the top of the 'stemness hierarchy tree' are adequately 'equipped' biologically to initiate and drive tumourigenesis. CSCs have been implicated in various solid malignancies including prostate cancer (PCa), where their existence seems to provide an explanation for the failure of tumour eradicating therapies. As CSCs are thought to share many properties with normal stem cells, understanding normal stem cells should shed light on the pathomechanisms of cancer and, importantly, on potential therapeutic interventions. The purpose of this paper is to review the existing data on CSCs in PCa, their putative phenotypic markers, potential role in tumour biology and relevance to therapy.

摘要

癌症干细胞(CSCs)假说假定,一小部分细胞是癌症起始和进展的原因。与随机和克隆进化模型不同,CSC理论提出肿瘤具有层级结构,只有“干性层级树”顶端的罕见细胞亚群在生物学上具备启动和驱动肿瘤发生的充分“条件”。CSCs已被认为与包括前列腺癌(PCa)在内的各种实体恶性肿瘤有关,其存在似乎为肿瘤根除疗法的失败提供了解释。由于CSCs被认为与正常干细胞具有许多共同特性,了解正常干细胞应有助于阐明癌症的发病机制,重要的是,有助于了解潜在的治疗干预措施。本文的目的是综述PCa中CSCs的现有数据、其假定的表型标志物、在肿瘤生物学中的潜在作用以及与治疗的相关性。

相似文献

1
Prostate cancer stem cells.
Cent European J Urol. 2011;64(4):196-200. doi: 10.5173/ceju.2011.04.art1. Epub 2011 Dec 9.
2
Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?
Cancer Immunol Immunother. 2011 Aug;60(8):1181-93. doi: 10.1007/s00262-011-1065-8. Epub 2011 Jun 19.
3
Cancer stem cells: progress and challenges in lung cancer.
Stem Cell Investig. 2014 Apr 15;1:9. doi: 10.3978/j.issn.2306-9759.2014.03.06. eCollection 2014.
4
Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Crit Rev Oncog. 2016;21(3-4):203-219. doi: 10.1615/CritRevOncog.2016016976.
5
The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma.
Gut Liver. 2012 Jan;6(1):29-40. doi: 10.5009/gnl.2012.6.1.29. Epub 2012 Jan 12.
6
Cancer stem cells and cancer therapy.
Tumour Biol. 2011 Jun;32(3):425-40. doi: 10.1007/s13277-011-0155-8. Epub 2011 Feb 12.
7
Cancer stem cells may contribute to the difficulty in treating cancer.
Genes Dis. 2016 Feb 10;3(1):7-10. doi: 10.1016/j.gendis.2016.01.001. eCollection 2016 Mar.
8
A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours.
Nature. 2011 Oct 19;478(7369):399-403. doi: 10.1038/nature10525.
9
Die hard: are cancer stem cells the Bruce Willises of tumor biology?
Cytometry A. 2009 Jan;75(1):67-74. doi: 10.1002/cyto.a.20690.
10
The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.
Asian J Urol. 2016 Oct;3(4):203-210. doi: 10.1016/j.ajur.2016.09.006. Epub 2016 Sep 20.

引用本文的文献

1
Therapeutic implications of cancer stem cells in prostate cancer.
Cancer Biol Med. 2023 Jun 5;20(6):401-20. doi: 10.20892/j.issn.2095-3941.2022.0714.
2
The role of FOSL1 in stem-like cell reprogramming processes.
Sci Rep. 2021 Jul 19;11(1):14677. doi: 10.1038/s41598-021-94072-0.
3
Cancer-stromal cell fusion as revealed by fluorescence protein tracking.
Prostate. 2020 Feb;80(3):274-283. doi: 10.1002/pros.23941. Epub 2019 Dec 17.
4
Stem cells - the key to cancer treatment.
Cent European J Urol. 2013;66(3):281-2. doi: 10.5173/ceju.2013.03.art8.

本文引用的文献

1
Prostate cancer stem cells: do they have a basal or luminal phenotype?
Horm Cancer. 2011 Feb;2(1):47-61. doi: 10.1007/s12672-010-0058-y.
2
Cells of origin in cancer.
Nature. 2011 Jan 20;469(7330):314-22. doi: 10.1038/nature09781.
3
Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells.
Mol Oncol. 2010 Oct;4(5):385-96. doi: 10.1016/j.molonc.2010.06.009. Epub 2010 Jul 14.
4
The role of telomeres and telomerase in stem cell aging.
FEBS Lett. 2010 Sep 10;584(17):3826-30. doi: 10.1016/j.febslet.2010.07.042. Epub 2010 Aug 3.
5
Identification of a cell of origin for human prostate cancer.
Science. 2010 Jul 30;329(5991):568-71. doi: 10.1126/science.1189992.
6
Stem cells and the niche: a dynamic duo.
Cell Stem Cell. 2010 Feb 5;6(2):103-15. doi: 10.1016/j.stem.2010.01.011.
7
Basal epithelial stem cells are efficient targets for prostate cancer initiation.
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2610-5. doi: 10.1073/pnas.0913873107. Epub 2010 Jan 25.
9
Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model.
Cancer Res. 2009 Nov 15;69(22):8555-62. doi: 10.1158/0008-5472.CAN-08-4673. Epub 2009 Nov 3.
10
Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells.
Eur Urol. 2010 Jul;58(1):162-71. doi: 10.1016/j.eururo.2009.08.026. Epub 2009 Sep 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验